Chloramphenicol is a potent antibiotic that bacteria fight with surprising metabolic ingenuity
In short: Discovered in 1947, chloramphenicol remains a vital tool against severe infections, yet its use is tempered by rare but fatal side effects. Beyond its clinical history, recent research reveals that bacteria do not just passively resist the drug; they actively remodel their internal metabolism to survive the stress it induces.
Chloramphenicol functions as a broad-spectrum antibiotic by inhibiting protein synthesis in bacteria. Since its discovery from Streptomyces venezuelae in 1947 and subsequent synthesis in 1949, it has been used to treat conditions ranging from meningitis to typhoid fever. However, because it can cause bone marrow suppression and, in rare cases, fatal aplastic anaemia, it is typically reserved for situations where safer alternatives are unavailable. The risk of these side effects varies significantly by administration method, with oral doses carrying a higher risk than topical eye drops.
Bacteria have evolved several ways to evade the drug, including mutating their 50S ribosomal subunits or producing enzymes like chloramphenicol acetyltransferase that deactivate the molecule. Research into Acinetobacter baumannii has shown that efflux pumps—proteins that actively expel toxins—are central to this resistance. Specifically, the CraA pump acts as a primary determinant of chloramphenicol resistance. When these pumps are deleted, bacteria do not simply die; they undergo complex transcriptomic reprogramming, activating oxidative stress defenses and altering amino acid metabolism to maintain redox balance.
The interaction between antibiotics and bacterial physiology is more nuanced than simple resistance. In some cases, such as with the isolate Acinetobacter sp. AL-9 from Ana Sagar Lake, exposure to chloramphenicol can even trigger enhanced biofilm formation. This suggests that efflux systems do more than just pump out drugs; they are integral to how bacteria manage metal homeostasis and environmental stress. Understanding this hierarchy of resistance and the metabolic cost of survival is critical for managing multidrug-resistant organisms as we continue to rely on older, established agents in modern medicine.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Chloramphenicol stress triggers oxidative adaptation in <i>Acinetobacter baumannii</i> ATCC19606 devoid of RND efflux pumps AdeAB or AdeIJ.
- Also: Chloramphenicol
- Also: Assessment data of antibiotic resistance patterns in bacteria from Ana Sagar Lake: Environmental and public health perspectives.
To cite this card, link to https://intellectplus.co.uk/app/health-chloramphenicol.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health, medicine and disease · More in Health · Latest · A–Z · All topics
